Skip to main content

Advertisement

SpringerLink
Log in

The role of therapeutic drug monitoring in the treatment of cytomegalovirus disease in kidney transplantation

  • Nephrology - Case Report
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Cytomegalovirus (CMV) infection is a common complication following solid organ transplantation that may severely affect the outcome of transplantation. Ganciclovir (GCV) and its prodrug valganciclovir are successfully used to prevent and treat CMV infection; however, in a small percentage of patients, CMV gene mutations may lead to drug resistance. GCV resistance is defined as increasing CMV viremia or progressive clinical disease during prolonged antiviral therapy, due to CMV gene mutation. This has emerged as a new challenge, especially because alternative drugs such as cidofovir and foscarnet have a number of important side effects. Here we report the case of a kidney transplanted patient who experienced life-threatening CMV disease, which initially appeared to be GCV-resistant, but was instead found to be associated with inadequate antiviral drug levels. The patient was then successfully treated by monitoring plasma GCV levels. We suggest using plasma GCV monitoring in the management of all cases of critical CMV disease, in which GCV resistance is suspected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. San Juan R, Aguado JM, Lumbreras C et al (2007) Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transpl 7(4):964–971

    Article  CAS  Google Scholar 

  2. Rubin RH (1990) Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12(Suppl 7):S754–S766

    Article  PubMed  Google Scholar 

  3. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB et al (1992) Simptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 53(1):68–72

    Article  PubMed  CAS  Google Scholar 

  4. Lumbreras C, Otero JR, Herrero JA et al (1993) Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. Antimicrob Agents Chemother 37(11):2490–2492

    Article  PubMed  CAS  Google Scholar 

  5. Hart GD, Paya CV (2001) Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 11(2):73–81

    Article  PubMed  CAS  Google Scholar 

  6. Emery VC (2001) Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 11(2):83–86

    Article  PubMed  CAS  Google Scholar 

  7. Brennan DC (2001) Cytomegalovirus in renal transplantation. J Am Soc Nephrol 12(4):848–855

    PubMed  CAS  Google Scholar 

  8. Limaye AP, Corey L, Koelle DM et al (2000) Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 19;356(9230):645–649

    Google Scholar 

  9. Nogueira E, Ozaki KS, Tomiyama H, Granato CF, Camara NO, Pacheco-Silva A (2006) The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Int Immunopharmacol 20;6(13–14): 2031–2037

    Google Scholar 

  10. Prichard MN, Kern ER (2011) The search for new therapies for human cytomegalovirus infections. Virus Res 157(2):212–221

    Article  PubMed  CAS  Google Scholar 

  11. Mendez JC, Sia IG, Tau KR et al (1999) Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy. Transplantation 67(5):755–757

    Article  PubMed  CAS  Google Scholar 

  12. Boivin G, Goyette N, Gilbert C et al (2005) Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis. J Med Virol 77:425–429

    Article  PubMed  CAS  Google Scholar 

  13. Luck S, Lovering A, Griffiths P, Sharland M (2011) Ganciclovir treatment in children: evidence of subtherapeutic levels. Int J Antimicrob Agents 37(5):445–448

    Article  PubMed  CAS  Google Scholar 

  14. Kotton CN, Kumar D, Caliendo AM et al (2010) International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 89:779–795

    Article  PubMed  Google Scholar 

  15. Faulds D, Heel RC (1990) Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infection. Drugs 39:597–638

    Article  PubMed  CAS  Google Scholar 

  16. Lurain NS, Chou S (2010) Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 23(4):689–712

    Article  PubMed  CAS  Google Scholar 

  17. Piketty C, Bardin C, Gilquin J et al (2000) Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis. Clin Microbiol Infect 6:117–120

    Article  PubMed  CAS  Google Scholar 

  18. Fishman JA, Doran MT, Volpicelli SH et al (2000) Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients. Transplantation 69:389–394

    Article  PubMed  CAS  Google Scholar 

  19. Tornatore KM, Garey KW, Saigal N et al (2001) Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clin Transplant 15:297–308

    Article  PubMed  CAS  Google Scholar 

  20. Erice A, Jordan MC, Chace BA et al (1987) Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised host. JAMA 257:3082–3087

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

All authors state no conflicts of interest.

Author information

Authors and Affiliations

  1. Unit of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

    Giulia Bedino, Pasquale Esposito, Francesca Bosio, Valeria Corradetti, Teresa Valsania, Chiara Rocca, Eleonora Francesca Pattonieri, Marilena Gregorini, Teresa Rampino & Antonio Dal Canton

Authors
  1. Giulia Bedino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pasquale Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Bosio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valeria Corradetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Teresa Valsania
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chiara Rocca
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eleonora Francesca Pattonieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marilena Gregorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Teresa Rampino
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Antonio Dal Canton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giulia Bedino.

Additional information

Giulia Bedino and Pasquale Esposito equally contributed to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bedino, G., Esposito, P., Bosio, F. et al. The role of therapeutic drug monitoring in the treatment of cytomegalovirus disease in kidney transplantation. Int Urol Nephrol 45, 1809–1813 (2013). https://doi.org/10.1007/s11255-012-0293-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0293-y

Keywords

Search

Navigation